In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Patterns of Failure After Stereotactic Radiosurgery for the Treatment of Recurrent High Grade Gliomas

    Final Number:
    1210

    Authors:
    Chibawanye I Ene MD; Megan Macomber MD; Jason Barber MS; Daniel L. Silbergeld MD; Jason K. Rockhill MD, PhD; Lia Halasz MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: There are no effective strategies for management of tumor progression in this patient population. Re-irradiation with gamma knife stereotactic radiosurgery (SRS) is one method for managing tumor progression, however, it is unclear if this treatment modality is efficacious at achieving local disease control.

    Methods: We reviewed 47 consecutive patients treated with gamma knife stereotactic radiosurgery (SRS) for recurrent high grade GBM (grade III and IV) between June 2006 and July 2013. The mean age was 52 years (range, 31-79). 39 patients (85%) and 44 patients (94%) received temozolomide and standard radiation therapy for their initial disease respectively. 7 patients (15%) and 38 patients (81%) underwent surgery or chemotherapy for tumor progression respectively. The mean prescription dose of 17.5 Gy to the 50% iso-dose surface (range, 12-22). We documented local disease control by evaluating failure location (in-field, marginal, distant), failure extent and time to failure

    Results: Treatment failure in patients older than 60 years (n=14, 30%) were more likely to be distant from the site of SRS (p=0.035). SRS doses (18-19Gy, 43% of patients) were associated with increased time to treatment failure (p=0.016). Surgery for tumor progression prior to SRS did not significantly affect failure location (p=0.942), extent (p=0.2) or prolong time to treatment failure (p=0.577). Median overall survival following SRS was 5 months with no significant difference between Grade III (n=10; 4.11 months) and IV (n=37; 5.48 months, p=0.686). Initial tumor grade did not significantly affect failure location (p=0.142), extent (p=0.451) or time to failure (p=0.686) following SRS.

    Conclusions: Majority of patients with high grade gliomas present with in-field treatment failure following GK SRS. Older patients tend to present with failure further removed from 50% iso-dose line. Surgery for tumor progression did not affect the pattern of tumor failure or time to failure following GK SRS.

    Patient Care: There is currently no standard of care for patients with recurrent high grade gliomas. Stereotactic radiosurgery may be a safe methods to achieve local disease control. Few studies have assessed the clinical relevance and patterns of failure following this treatment modality for grade III and IV gliomas. Our data provides insights into prognostic factors affecting the failure patterns seen following SRS.

    Learning Objectives: By the conclusion of the session, participants should be able to: 1. Describe the management of recurrent high grade gliomas 2. Describe the pattern of failure following gamma knife therapy for recurrent high grade glioma

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy